Reviews
Description
Molecular Targets
Annunziata, Christina M. (et al.)
Preclinical Screening for New Anticancer Agents
Burger, Angelika M. (et al.)
Natural Product Screening
McKee, Tawnya C. (et al.)
Defining the Starting Dose: Should It Be mg/kg, mg/m
Gao, Bo (et al.)
Phase 0 Trials in Oncology
Kummar, Shivaani (et al.)
Phase I Trials in Oncology: Design and Endpoints
Glen, Hilary (et al.)
Quantitative Analytical Methods: Development and Clinical Considerations
Gardner, Erin R.
Validation and Control of Bioanalytical Methods
Karnes, H. Thomas (et al.)
Anticancer Clinical Pharmacology Overview
Dandamudi, Uday B. (et al.)
Pharmacokinetic Modeling
Li, Jing (et al.)
Pharmacometrics
Brar, Satjit S. (et al.)
Pharmacodynamic Modeling
Bauer, Kenneth S. (et al.)
Protein Binding
Sparreboom, Alex (et al.)
Metabolism (Non-CYP Enzymes)
Jamieson, David (et al.)
Pharmacogenomics and Cancer Therapy: Somatic and Germline Polymorphisms
Patel, Jai N. (et al.)
Cytochrome P450
Ando, Yuichi
Polymorphisms in Genes of Drug Targets and Metabolism
Bohanes, Pierre (et al.)
DNA Repair: ERCC1, Nucleotide Excision Repair, and Platinum Resistance
Reed, Eddie (et al.)
Drug Interactions
Rivory, Laurent P.
ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition
Massey, Paul R. (et al.)
Solute Carriers
Ho, Richard H. (et al.)
High-Throughput Platforms in Drug Metabolism and Transport Pharmacogenetics
English, Bevin C. (et al.)
Intrathecal Administration
Kilburn, Lindsay B. (et al.)
Microdialysis
Combest, Austin J. (et al.)
Regional Drug Delivery for Inoperable Pulmonary Malignancies
Schrump, David S.
Blood-Brain Barrier and CNS Malignancy
Balmanoukian, Ani (et al.)
Radiation and Altering Clinical Pharmacology
Smart, DeeDee (et al.)
Therapeutic Cancer Vaccines: An Emerging Approach to Cancer Treatment
Madan, Ravi A. (et al.)
Recombinant Immunotoxins
Kreitman, Robert J.
Monoclonal Antibodies
Bai, Shuang (et al.)
Clinical Pharmacology in Pediatrics
Tagen, Michael (et al.)
Clinical Pharmacology in the Older Adult
Slattum, Patricia W. (et al.)
Organ Dysfunction Trials: Background, Historical Barriers, Progress in Overcoming Barriers, and Suggestions for Future Trials
Kummar, Shivaani (et al.)
Drug Formulations: How these Affects Anticancer Drug
Lagas, Jurjen S. (et al.)
Nanotechnology in Cancer
Janát-Amsbury, Margit M. (et al.)
Imaging in Drug Development
Kurdziel, Karen A. (et al.)
Exposure-Response Relationships of Anticancer Agents: Application in Drug Development and Drug Label
Rahman, Atiqur
The Role of Phase III Trials in Modern Drug Development
Murphy, Janet E. (et al.)
Clinical Trial Designs for Approval of New Anticancer Agents
Chadha, Manpreet K. (et al.)
Clinical Pharmacogenetics
Sachidanandam, Kamakshi (et al.)
EXTRA 10 % discount with code: EXTRA
The promotion ends in 17d.10:02:24
The discount code is valid when purchasing from 10 €. Discounts do not stack.
Molecular Targets
Annunziata, Christina M. (et al.)
Preclinical Screening for New Anticancer Agents
Burger, Angelika M. (et al.)
Natural Product Screening
McKee, Tawnya C. (et al.)
Defining the Starting Dose: Should It Be mg/kg, mg/m
Gao, Bo (et al.)
Phase 0 Trials in Oncology
Kummar, Shivaani (et al.)
Phase I Trials in Oncology: Design and Endpoints
Glen, Hilary (et al.)
Quantitative Analytical Methods: Development and Clinical Considerations
Gardner, Erin R.
Validation and Control of Bioanalytical Methods
Karnes, H. Thomas (et al.)
Anticancer Clinical Pharmacology Overview
Dandamudi, Uday B. (et al.)
Pharmacokinetic Modeling
Li, Jing (et al.)
Pharmacometrics
Brar, Satjit S. (et al.)
Pharmacodynamic Modeling
Bauer, Kenneth S. (et al.)
Protein Binding
Sparreboom, Alex (et al.)
Metabolism (Non-CYP Enzymes)
Jamieson, David (et al.)
Pharmacogenomics and Cancer Therapy: Somatic and Germline Polymorphisms
Patel, Jai N. (et al.)
Cytochrome P450
Ando, Yuichi
Polymorphisms in Genes of Drug Targets and Metabolism
Bohanes, Pierre (et al.)
DNA Repair: ERCC1, Nucleotide Excision Repair, and Platinum Resistance
Reed, Eddie (et al.)
Drug Interactions
Rivory, Laurent P.
ABC Transporters: Involvement in Multidrug Resistance and Drug Disposition
Massey, Paul R. (et al.)
Solute Carriers
Ho, Richard H. (et al.)
High-Throughput Platforms in Drug Metabolism and Transport Pharmacogenetics
English, Bevin C. (et al.)
Intrathecal Administration
Kilburn, Lindsay B. (et al.)
Microdialysis
Combest, Austin J. (et al.)
Regional Drug Delivery for Inoperable Pulmonary Malignancies
Schrump, David S.
Blood-Brain Barrier and CNS Malignancy
Balmanoukian, Ani (et al.)
Radiation and Altering Clinical Pharmacology
Smart, DeeDee (et al.)
Therapeutic Cancer Vaccines: An Emerging Approach to Cancer Treatment
Madan, Ravi A. (et al.)
Recombinant Immunotoxins
Kreitman, Robert J.
Monoclonal Antibodies
Bai, Shuang (et al.)
Clinical Pharmacology in Pediatrics
Tagen, Michael (et al.)
Clinical Pharmacology in the Older Adult
Slattum, Patricia W. (et al.)
Organ Dysfunction Trials: Background, Historical Barriers, Progress in Overcoming Barriers, and Suggestions for Future Trials
Kummar, Shivaani (et al.)
Drug Formulations: How these Affects Anticancer Drug
Lagas, Jurjen S. (et al.)
Nanotechnology in Cancer
Janát-Amsbury, Margit M. (et al.)
Imaging in Drug Development
Kurdziel, Karen A. (et al.)
Exposure-Response Relationships of Anticancer Agents: Application in Drug Development and Drug Label
Rahman, Atiqur
The Role of Phase III Trials in Modern Drug Development
Murphy, Janet E. (et al.)
Clinical Trial Designs for Approval of New Anticancer Agents
Chadha, Manpreet K. (et al.)
Clinical Pharmacogenetics
Sachidanandam, Kamakshi (et al.)
Reviews